ontario research institute

CHEO scientist advances biotherapeutics as published in Cancer C...

EurekAlert! - Cancer  Mon, 10/17/2011 - 22:00

(Children's Hospital of Eastern Ontario Research Institute) Dr. David Stojdl, a scientist from the Children's Hospital of Eastern Ontario Research Institute at the University of Ottawa has found a way to trick resistant cancer cells into committing suicide following oncolytic virus therapy.


 

Data indicates rising adoption of technology in Canadian clinica...

EurekAlert! - Medicine and Health  Thu, 12/17/2009 - 23:00

(Children's Hospital of Eastern Ontario Research Institute) A research team led by Dr. Khaled El Emam, the Canada Research Chair in Electronic Health Information at the CHEO Research Institute, evaluated the use of technology in Canadian clinical trials, and found that a significant proportion (41 percent) have moved away from collecting and managing trial data using only paper records.


 

Novel K-anonimity algorithm safeguards access to data

EurekAlert! - Medicine and Health  Thu, 11/19/2009 - 23:00

(Children's Hospital of Eastern Ontario Research Institute) As electronic health records become more widely deployed, increasing amounts of health information are being collected.

This data has many beneficial applications, such as research, public health, and health system planning. In a recent study, Dr.


 

New study looks at re-identification risks

EurekAlert! - Medicine and Health  Tue, 10/13/2009 - 22:00

(Children's Hospital of Eastern Ontario Research Institute) A recent study led by Dr. Khaled El Emam, the Canada Research Chair in Electronic Health Information at the CHEO Research Institute, found that the information in hospital prescription records can quite easily re-identify patients.

In his study, titled "Evaluating the Risk of Re-identification of Patients from Hospital Prescription Records, he demonstrates the importance of ensuring the proper de-identification of patient records.


 

CHEO RI study uses sophisticated genetic engineering to improve ...

EurekAlert! - Medicine and Health  Tue, 10/06/2009 - 22:00

(Children's Hospital of Eastern Ontario Research Institute) A study to be published today in the leading international journal Cell Metabolism describes how a research group led by Dr.

Robert Screaton, who holds the Canada Research Chair in Apoptotic Signaling at the University of Ottawa, used sophisticated genetic engineering to remove or "knock out" the Lkb1 gene from beta cells of laboratory mice.

The result was an increase in both the size and number of beta cells, as well as greater amounts of insulin stored and released by the cells.